| Abbreviations | Full name |
| 2-AG | 2-arachidonoylglycerol |
| 5-HT1A | serotonin receptor 1A |
| AEA | anandamide |
| Aβ | amyloid beta |
| CB1 | cannabinoid receptor type 1 |
| CB2 | cannabinoid receptor type 2 |
| CBC | cannabichromene |
| CBCA | canabichromenic acid |
| CBD | cannabidio |
| CBDA | cannabidiolic acid |
| CBG | Cannabigerol |
| CBGA | Cannabigerolic acid |
| CBN | Cannabinol |
| CBNA | Cannabinolic acid |
| COX-1 | Cyclooxygenase-1 |
| COX-2 | Cyclooxygenase-2 |
| Δ-9-THC | Delta-9-tetrahydrocannabinol |
| DAGL | diacylglycerol lipase |
| DS | Dravet Syndrome |
| ECS | Endocannabinoid system |
| ECs | Endocannabinoids |
| EMA | European Medicines Agency |
| ER | endoplasmic reticulum |
| EU | European Union |
| FAAH | Fatty acid amide hydrolase |
| FDA | Food and Drug Administration |
| GPP | Geranyl diphosphate |
| HDF | Human dermal fibroblasts |
| HDL | High-density lipoprotein |
| HRPC | Hormone-refractory prostate cancer |
| IBD | Inflammatory bowel disease |
| iNOS | Nitric oxide synthase |
| IOP | Intraocular pressure |
| LGS | Lennox Gastaut Syndrome |
| MCD | Methionine/choline-deficient |
| MDSCs | Monocytic-myeloid-derived suppressor cells |
| MGL | Monoacylglycerol lipase |
| MRSA | Methicillin-resistant strains |
| MS | Multiple sclerosis |
| NASH | Non-alcoholic steatohepatitis |
| PPAR | Peroxisome proliferator-activated receptor |
| ROS | Reactive oxygen species |
| SOD-1 | Superoxide dismutase-1 |
| THC | Tetrahydrocannabinol |
| THCA | Tetrahydrocannabinolic acid |
| TME | Tumor microenvironment |
| Tregs | T-regulatory cells |
| TRPM8 | transient receptor potential cation channel 8 |
| TRPM8 | TRP melastatin type 8 |
| TRPV | transient receptor potential vanilloid |
| TSC | Tuberous Sclerosis Complex |
| α2AR | α2-adrenoceptor |
| 2-AG | 2-arachidonoylglycerol |